HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Ophthalmic Oncologists

Ophthalmic Oncologists are essential experts in diagnosing and treating tumors that affect the eye, eyelid, orbit, and surrounding structures. These tumors may be benign or malignant, including conditions such as ocular melanoma, retinoblastoma, and conjunctival carcinoma. Early and precise detection is critical, and these professionals use advanced diagnostic tools like ocular imaging, slit-lamp exams, MRIs, and biopsies to thoroughly assess each case. Treatment is carefully tailored to preserve both vision and eye health, often involving surgery, localized radiation, chemotherapy, or laser therapy. Their specialized approach ensures that interventions are as effective and minimally invasive as possible.

Because the eye is such a delicate and vital organ, even small tumors require expert care and precise management. The visual and cosmetic outcomes of treatment are always key considerations in the care plan. Ophthalmic Oncologists play an essential role in helping patients cope with the emotional and visual impact of eye tumors. They work closely with multidisciplinary teams—such as oculoplastic surgeons, radiologists, medical oncologists, and visual rehabilitation specialists—to provide coordinated, comprehensive care. Long-term follow-up is key to tracking recovery, managing complications, and catching any recurrence early. These specialists combine medical precision with empathetic patient support, guiding individuals through complex diagnoses while prioritizing quality of life and long-term well-being.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp